Immune checkpoint inhibitors (ICI) are the standard of care for various malignancies and have been associated with a wide spectrum of complications that are phenotypically akin to primary autoimmune diseases. While the literature on these toxicities is growing. there is a paucity of data regarding ICI-associated scleroderma which can carry significant morbidity and limit the ability t... https://www.ealisboa.com/